|
|
Volumn 51, Issue 1, 2011, Pages 181-187
|
|
2010: Year in review
|
|
Author keywords
clinical trials; headache; migraine; research
|
|
Indexed keywords
ADX 10059;
ANTIMIGRAINE AGENT;
BGC20 1531;
BGG 492;
BOTULINUM TOXIN A;
BUPIVACAINE;
CANDESARTAN HEXETIL;
CYCLOBENZAPRINE;
DIHYDROERGOCRYPTINE;
DIHYDROERGOTAMINE;
DR 105;
DULOXETINE;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHOSUXIMIDE;
GABAPENTIN ENACARBIL;
KETOPROFEN;
LASMIDITAN;
LEVADEX;
LY 2300559;
LY 2590443;
METHYLPREDNISOLONE;
METOCLOPRAMIDE;
NXN 188;
NXN 288;
NXN 462;
OXYTOCIN;
PROPRANOLOL PLUS TOPIRAMATE;
RAMELTEON;
SUMATRIPTAN;
TELCAGEPANT;
TI 001;
TRIPTAN DERIVATIVE;
UNCLASSIFIED DRUG;
VALPROIC ACID DERIVATIVE;
ZELRIX;
BRONCHITIS;
CARDIOVASCULAR DISEASE;
CHRONIC DAILY HEADACHE;
CLINICAL TRIAL (TOPIC);
CONNECTIVE TISSUE DISEASE;
DIZZINESS;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
FATIGUE;
HEADACHE;
HUMAN;
HYPERTENSION;
INJECTION SITE PAIN;
LIVER FUNCTION TEST;
MENSTRUAL MIGRAINE;
MIGRAINE;
MULTICENTER STUDY (TOPIC);
MUSCLE SPASM;
MUSCLE STIFFNESS;
MUSCLE WEAKNESS;
MUSCULOSKELETAL DISEASE;
MUSCULOSKELETAL PAIN;
NECK PAIN;
NERVE STIMULATION;
PARESIS;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PTOSIS;
REVIEW;
SIDE EFFECT;
TREATMENT RESPONSE;
UNSPECIFIED SIDE EFFECT;
CHRONIC DISEASE;
CLINICAL TRIALS AS TOPIC;
DRUG APPROVAL;
ELECTRIC STIMULATION THERAPY;
HEADACHE;
HEADACHE DISORDERS;
HUMANS;
MIGRAINE DISORDERS;
SPINAL NERVES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 78650958010
PISSN: 00178748
EISSN: 15264610
Source Type: Journal
DOI: 10.1111/j.1526-4610.2010.01815.x Document Type: Review |
|
Times cited : (2)
|
|
References (0)
|
